US Patent 9758465 Controlled release pharmaceutical formulations
Patent 9758465 was granted and assigned to United Therapeutics on September, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+237 characters)
Article
Patent abstract
Disclosed herein are drug release polymer compounds and compositions comprising prostacyclin compounds of Formula (I), and methods of preparing the same. A preferred polymer has a repeating unit of the following structure:
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09758465 Controlled release pharmaceutical formulations US Patent 9758465 Controlled release pharmaceutical formulations
Infobox
Patent Number
0975846500
Patent Number
975846500
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
097584650
Date of Patent
September 12, 2017
0Patent Application Number
142643920
Date Filed
April 29, 2014
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
097584650
Date of Patent
September 12, 2017
0Patent Application Number
142643920
Date Filed
April 29, 2014
0Patent Primary Examiner
Edits on 14 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09758465 Controlled release pharmaceutical formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09758465
Date of patent
September 12, 2017
Patent application number
14264392
Date Filed
April 29, 2014
Patent primary examiner
Find more entities like US Patent 9758465 Controlled release pharmaceutical formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
